Cargando…
Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options
Anti-vascular endothelial growth factor (anti-VEGF) therapy currently plays a central role in the treatment of numerous retinal diseases, most notably exudative age-related macular degeneration (eAMD), diabetic retinopathy and retinal vein occlusions. While offering significant functional and anatom...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145407/ https://www.ncbi.nlm.nih.gov/pubmed/33946803 http://dx.doi.org/10.3390/cells10051049 |